FALLS CHURCH, Va., April 9, 2020 /PRNewswire-PRWeb/ -- Does one fully understand the EU-MDR's postmarket surveillance (PMS) requirements and how they interconnect?

Collect and analyze data, write an evaluation report and if necessary, implement a postmarketing clinical follow-up plan (PMCF).

Join us to discuss the EU-MDR postmarket surveillance system and get guidance on how to implement the requirements:

• Prepare your PMS plan
• Formulate other related plans — the complaint management plan, the trend report plan and if applicable, the PMCF plan
• Determine the reports required for PMS
• Ascertain when to prepare a PMCF plan
• Understand the content of the PMCF Evaluation Report
• Understand how PMS data, PMCF data and risk management interconnect

Ensure one stays current with the EU's new PMS requirements.

This webinar is part three of a three-part online series on EU-MDR readiness. Save 25% by ordering the complete three-part series:

Part II: Tips for Assessing Your Readiness Prior to Notified Body Review
Friday, April 10, 2020. Register for the live presentation.

Part I: The Real Role of the Person Responsible for Regulatory Readiness & Compliance
Recorded on Thursday, Feb. 20, 2020. Purchase as an encore presentation.

Interested in registering multiple sites?
Call 888.838.5578 in the U.S. or +1 703.538.7600 globally
to learn about our special multisite discount.

Webinar Details:
EU-MDR: Are You Ready?
An Exclusive Three-Part FDAnews Webinar Series
Part III: Ensuring Your Postmarket Surveillance Readiness
Thursday, April 23, 2020 • 1:30 p.m.-3:00 p.m. EDT
https://www.fdanews.com/part3eumdr

Tuition:
$287 per site

Easy Ways to Register:
Online: https://www.fdanews.com/part3eumdr
By phone: 888.838.5578 or 703.538.7600

About FDAnews:
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations

SOURCE FDAnews